Nuvo Research provides update on the PENNSAID Viscous Solution development program
MISSISSAUGA, ON, Sept. 14, 2011 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company dedicated to building aportfolio of products for the topical treatment of pain and thedevelopment of its immune modulating drug candidate…
September 14th, 2011
Posted in
Drug